A Kenyan doctor's perspective

Article

A Kenyan doctor's perspective

Kenya is one of the best known developing countries in the world. At the moment the health sector is undergoing major reforms. These reforms aim at responding to the following constraints: decline in health sector expenditure, inefficient utilisation of resources, centralized decision making, inequitable management information systems, outdated health laws, inadequate management skills at the district level, worsening poverty levels, increasing burden of disease and rapid population growth.

Eye conditions fall among the top ten reasons for outpatient cases reported countrywide. Cataract is the leading cause of blindness and cataract blindness affects more women than men.

However recent blindness surveys in three districts in Kenya showed that the gap between blindness levels in males and females, as well as in cataract surgery coverage was much narrower than anticipated. For example in Nakuru the cataract surgery coverage was 78.3 % for males and 77.6 % for females.

Programmes that aim to empower women thus go a long way in closing the gap in access to eye care even in developing countries. These include programmes that allow women to access finance without reference to husbands and other males in their lives. In districts where such programmes exist, queues at eye units will tend to have as many women as men.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.